SpectraCure raises approximately SEK 140 million through a fully subscribed rights issue
SpectraCure AB’s (publ) (Nasdaq First North Premier Growth Market: SPEC) (“SpectraCure” or the “Company”) fully guaranteed new Units issue with preferential rights for the Company’s existing shareholders (the “Rights Issue”), was fully subscribed. Through the Rights Issue, SpectraCure will receive proceeds amounting to approximately SEK 140 million before transaction costs. Not for publication, distribution or […]
Subscription period postponed for the rights issue. Other conditions remain unchanged
SpectraCure AB (publ) postpones the subscription period for the rights issue which was announced on 5 May 2020. The new subscription period is between Friday, 5 June 2020 and Tuesday, 23 June 2020 inclusive. All other terms and conditions of the rights issue remain unchanged. The Board of Directors of SpectraCure AB (publ) has resolved to postpone […]
SpectraCure’s MSEK 140 rights issue of units is fully guaranteed
THIS PRESS RELEASE MAY NOT BE ANNOUNCED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, JAPAN, CANADA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR RULES OR WOULD REQUIRE ADDITIONAL REGISTRATION OR OTHER ACTION. A top guarantee up to 100 percent of the rights issue has been […]
